ANAL CANCER RECURRENT

ANAL CANCER RECURRENT was reported 21 times

ANAL CANCER RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD4-directed Blocking Antibody [EPC] 1 0.0019
1 CCR5 Co-receptor Antagonist [EPC] 1 0.0004
2 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
3 Protease Inhibitor [EPC] 2 0.0000
4 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
5 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
6 Androgen [EPC] 1 0.0000
7 Provitamin D2 Compound [EPC] 1 0.0000
8 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
9 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
10 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
11 Interleukin-23 Antagonist [EPC] 2 0.0000
12 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
13 Integrin Receptor Antagonist [EPC] 1 0.0000
14 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
15 Prostaglandin Analog [EPC] 1 0.0000
16 Aminosalicylate [EPC] 1 0.0000
17 Microtubule Inhibitor [EPC] 1 0.0000
18 Interferon beta [EPC] 1 0.0000
19 Mood Stabilizer [EPC] 1 0.0000
20 Opioid Agonist [EPC] 1 0.0000
21 Platinum-based Drug [EPC] 1 0.0000
22 Vitamin D [EPC] 1 0.0000
23 beta-Adrenergic Blocker [EPC] 1 0.0000
24 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
25 Vitamin B12 [EPC] 1 0.0000
26 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
27 Vitamin C [EPC] 1 0.0000
28 GLP-1 Receptor Agonist [EPC] 1 0.0000
29 Atypical Antipsychotic [EPC] 1 0.0000
30 Loop Diuretic [EPC] 1 0.0000
31 Proton Pump Inhibitor [EPC] 1 0.0000
32 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
33 Corticosteroid [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000